Cigna Corporation (NYSE:CI) Chairman Isaiah Harris, Jr. sold 212 shares of the firm’s stock in a transaction that occurred on Monday, December 11th. The stock was sold at an average price of $209.35, for a total transaction of $44,382.20. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Cigna Corporation (NYSE:CI) traded up $0.51 on Friday, reaching $204.14. 3,322,424 shares of the company’s stock were exchanged, compared to its average volume of 1,131,232. The company has a quick ratio of 0.39, a current ratio of 0.39 and a debt-to-equity ratio of 0.37. The stock has a market cap of $50,219.71, a P/E ratio of 19.62, a price-to-earnings-growth ratio of 1.56 and a beta of 0.50. Cigna Corporation has a 1 year low of $133.11 and a 1 year high of $212.46.

Cigna (NYSE:CI) last posted its quarterly earnings data on Thursday, November 2nd. The health services provider reported $2.83 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.36 by $0.47. The firm had revenue of $10.38 billion for the quarter, compared to the consensus estimate of $10.17 billion. Cigna had a net margin of 5.74% and a return on equity of 18.85%. The business’s revenue for the quarter was up 5.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.94 EPS. sell-side analysts forecast that Cigna Corporation will post 10.34 EPS for the current fiscal year.

Several analysts have recently weighed in on CI shares. Jefferies Group lifted their price objective on shares of Cigna from $221.00 to $231.00 and gave the company a “buy” rating in a research note on Friday, November 3rd. Zacks Investment Research lowered shares of Cigna from a “buy” rating to a “hold” rating in a research note on Friday, November 10th. Citigroup lifted their price objective on shares of Cigna from $198.00 to $231.00 and gave the company a “buy” rating in a research note on Friday, November 3rd. BMO Capital Markets started coverage on shares of Cigna in a research note on Monday, October 16th. They issued a “market perform” rating and a $210.00 price objective for the company. Finally, Morgan Stanley lifted their price objective on shares of Cigna from $195.00 to $223.00 and gave the company an “overweight” rating in a research note on Friday, November 3rd. Three equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Cigna has an average rating of “Buy” and a consensus target price of $201.50.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. JPMorgan Chase & Co. boosted its holdings in shares of Cigna by 40.8% in the 2nd quarter. JPMorgan Chase & Co. now owns 4,088,728 shares of the health services provider’s stock worth $684,413,000 after buying an additional 1,184,632 shares during the last quarter. Investec Asset Management LTD boosted its holdings in shares of Cigna by 35.4% in the 3rd quarter. Investec Asset Management LTD now owns 1,849,598 shares of the health services provider’s stock worth $345,764,000 after buying an additional 483,904 shares during the last quarter. FMR LLC boosted its holdings in shares of Cigna by 6.7% in the 2nd quarter. FMR LLC now owns 6,909,638 shares of the health services provider’s stock worth $1,156,604,000 after buying an additional 432,978 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Cigna by 4,082.8% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 438,231 shares of the health services provider’s stock worth $73,355,000 after buying an additional 427,754 shares during the last quarter. Finally, Vanguard Group Inc. boosted its holdings in shares of Cigna by 2.5% in the 2nd quarter. Vanguard Group Inc. now owns 17,130,735 shares of the health services provider’s stock worth $2,867,514,000 after buying an additional 424,469 shares during the last quarter. 87.85% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: This news story was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of U.S. & international copyright legislation. The original version of this news story can be viewed at https://www.thecerbatgem.com/2017/12/16/isaiah-harris-jr-sells-212-shares-of-cigna-corporation-ci-stock.html.

Cigna Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Insider Buying and Selling by Quarter for Cigna (NYSE:CI)

Receive News & Stock Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related stocks with our FREE daily email newsletter.